High Dimensionality Reduction and Immune Phenotyping of Natural Killer and Invariant Natural Killer Cells in Latent Tuberculosis-Diabetes Comorbidity
Open Access
- 21 February 2022
- journal article
- research article
- Published by Wiley in Journal of Immunology Research
- Vol. 2022, 1-12
Abstract
Natural killer (NK) and invariant NKT (iNKT) cells are unique innate lymphocytes that coordinate diverse immune responses and display antimycobacterial potential. However, the role of NK and iNKT cells expressing cytokines, cytotoxic, and immune markers in latent tuberculosis (LTB), diabetes mellitus (DM), or preDM (PDM) and nonDM (NDM) comorbidities is not known. Thus, we have studied the unstimulated (UNS), Mycobacterium tuberculosis (Mtb [PPD, WCL]), and mitogen (P/I)-stimulated NK and iNKT cells expressing Type 1 (IFNγ, TNFα, and IL-2), Type 17 (IL-17A, IL-17F, and IL-22) cytokines, cytotoxic (perforin, granzyme B, and granulysin) and immune (GMCSF, PD-1, and CD69) markers in LTB comorbidities by dimensionality reduction and flow cytometry. Our results suggest that LTB DM and PDM individuals express diverse NK and iNKT cell immune clusters compared to LTB NDM individuals. In UNS condition, frequencies of NK and iNKT cells expressing markers are not significantly different. After Mtb antigen stimulation, NK cell expressing [Type 1 (IFNγ, TNFα, and IL-2), GMCSF in PPD and IFNγ in WCL), Type 17 [(IL-17A), PD-1 in PPD), (IL-17A, IL-17F, and IL-22), PD-1 in WCL], and cytotoxic (perforin, granzyme B in PPD, and WCL)] marker frequencies were significantly reduced in LTB DM and/or PDM individuals compared to LTB NDM individuals. Similarly, iNKT cells expressing [Type 1 (IFNγ, IL-2), GMCSF in PPD), TNFα, GMCSF in WCL), Type 17 (IL-17A), PD-1 in PPD, IL-17F in WCL) cytokines were increased and cytotoxic or immune (perforin, granzyme B, granulysin), CD69 in PPD, perforin and CD69 in WCL] marker frequencies were significantly diminished in LTB DM and/or PDM compared to LTB NDM individuals. Finally, NK and iNKT cell frequencies did not exhibit significant differences upon positive control antigen stimulation between the study population. Therefore, altered NK cell and iNKT cells expressing cytokines, cytotoxic, and immune markers are characteristic features in LTB PDM/DM comorbidities.Keywords
Funding Information
- Division of Intramural Research
This publication has 39 references indexed in Scilit:
- Invariant natural killer T cells: an innate activation scheme linked to diverse effector functionsNature Reviews Immunology, 2013
- Prevalence of Diabetes and Pre-Diabetes and Associated Risk Factors among Tuberculosis Patients in IndiaPLOS ONE, 2012
- Dysfunction of Natural Killer T Cells in Patients with Active Mycobacterium tuberculosis InfectionInfection and Immunity, 2012
- The spectrum of latent tuberculosis: rethinking the biology and intervention strategiesNature Reviews Microbiology, 2009
- Cell-Mediated Immune Responses in TuberculosisAnnual Review of Immunology, 2009
- Alteration of the relative levels of iNKT cell subsets is associated with chronic mycobacterial infectionsClinical Immunology, 2008
- Functions of natural killer cellsNature Immunology, 2008
- Incidence of Type 2 diabetes in England and its association with baseline impaired fasting glucose: The Ely study 1990–2000Diabetic Medicine, 2007
- NK Cells and Type 1 DiabetesJournal of Immunology Research, 2006
- NK CELL RECOGNITIONAnnual Review of Immunology, 2005